DBV Technologies S.A. (DBVT) Financials
A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 10, 2026; every other figure is from the SEC filings on this page. Not financial advice.
Newest figures come from the 10-Q for Q2 FY2026, filed Jul 16, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the DBVT SEC filings page.
DBV Technologies S.A. (DBVT) reported $4.9M in revenue over the twelve months to Jun 30, 2026, up 27.1% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 7 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
DBV Technologies is a development-stage business whose operations consume cash and depend heavily on periodic external financing.
R&D spending was$116.7M against revenue of$5.6M , making development investment the dominant economic activity rather than a cost attached to an established sales base. Operating cash flow of-$121.2M nearly matched free cash flow of-$121.7M , indicating that reported losses are translating into cash use primarily through ongoing operations.
FY2025 financing supplied
Liquidity of 19.2 months of reported outflow and a 3.7x current ratio indicate meaningful short-term resources relative to near-term liabilities at FY2025 end. With capital expenditures of
Financial Health Signals
Scored against emerging companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →
Health score ≠ stock price. This rates the quality of DBV Technologies S.A.'s business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
DBV Technologies S.A. held $194.2M in cash, cash equivalents and investments at the end of fiscal year 2025, and its operations used $121.2M of cash that year. Cash Runway ranks emerging companies on the size of that balance against the outflow behind it, and DBV Technologies S.A. scores 45/100 among other emerging companies.
DBV Technologies S.A. had 296M shares outstanding at the end of fiscal year 2025. Dilution ranks emerging companies on how fast that count has grown over three years, where a slower rise is the better one, and DBV Technologies S.A. scores 14/100 among other emerging companies.
DBV Technologies S.A. spent $116.7M on research and development in fiscal year 2025, which was 76.4% of its operating costs that year. R&D Intensity ranks emerging companies on the share of operating costs that goes into research, and DBV Technologies S.A. scores 95/100 among other emerging companies.
DBV Technologies S.A. reported revenue of $5.6M in fiscal year 2025, against $4.2M in fiscal year 2024. Revenue Progress ranks emerging companies on the three-year path of that line, and DBV Technologies S.A. scores 8/100 among other emerging companies.
DBV Technologies S.A.'s operations used $121.2M of cash in fiscal year 2025, against $104.5M used in fiscal year 2024. Burn Trend ranks emerging companies on which way that figure has moved over three years, and DBV Technologies S.A. scores 28/100 among other emerging companies.
DBV Technologies S.A.'s cash, cash equivalents and investments came to $194.2M at the end of fiscal year 2025, against $64.9M of total liabilities. Balance Sheet ranks emerging companies on that comparison, and DBV Technologies S.A. scores 82/100 among other emerging companies.
DBV Technologies S.A. scores 2.08, placing it in the grey zone between 1.81 and 2.99. The score is driven primarily by a large market capitalization ($615.9M) relative to total liabilities ($64.9M). This signals moderate financial risk that warrants monitoring.
Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.
DBV Technologies S.A. passes 3 of 7 computable financial strength tests (2 of the nine could not be computed from available data). 2 of 4 profitability signals pass, 1 of 2 leverage/liquidity signals pass, neither operating efficiency signal passes.
DBV Technologies S.A. reported a net loss of $146.9M while operations used $121.2M of cash. With neither figure positive, the ratio between the two carries no quality signal.
Key Financial Metrics
Earnings & Revenue
DBV Technologies S.A. generated $700K in revenue in Q2 2026. This represents a decrease of 53.3% from the same quarter a year earlier. Against the prior quarter it is down 22.2%.
DBV Technologies S.A. reported -$50.4M in net income in Q2 2026. This represents a decrease of 20.3% from the same quarter a year earlier. Against the prior quarter it is down 5.9%.
DBV Technologies S.A. earned -$0.12 per diluted share (EPS) in Q2 2026. Against the prior quarter it is down 9.1%.
Not reported for Q2 2026.
Cash & Balance Sheet
DBV Technologies S.A. recorded an outflow of $53.0M in free cash flow in Q2 2026, representing a cash shortfall after capex. This represents a decrease of 56.3% from the same quarter a year earlier. Against the prior quarter it is down 7.1%.
DBV Technologies S.A. held $174.9M in cash as of Q2 2026; long-term debt is not reported for that period.
Not reported for Q2 2026.
Margins & Returns
DBV Technologies S.A.'s ROE was -31.4% in Q2 2026, measuring profit generated per dollar of shareholder equity. This is up 17.2 percentage points from the same quarter a year earlier. Against the prior quarter it is down 8.5 percentage points.
Not reported for Q2 2026.
Not shown for Q2 2026: the reported ratio is below -100.0% of revenue, so it does not read as a share of revenue.
Not shown for Q2 2026: the reported ratio is below -100.0% of revenue, so it does not read as a share of revenue.
Capital Allocation
DBV Technologies S.A. invested $31.2M in research and development in Q2 2026. This represents a decrease of 7.4% from the same quarter a year earlier. Against the prior quarter it is down 6.6%.
DBV Technologies S.A. invested $400K in capex in Q2 2026, funding long-term assets and infrastructure. It is unchanged from the prior quarter.
Not reported for Q2 2026.
DBVT Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Revenue | $700K-53.3% | $900K+12.5% | $562K+10.0% | $2.8M+158.8% | $1.5M+29.2% | $800K-43.1% | $511K-94.2% | $1.1M-54.8% |
| R&D Expenses | $31.2M-7.4% | $33.4M+55.3% | $32.9M+73.9% | $28.6M+20.9% | $33.7M+32.8% | $21.5M+0.5% | $18.9M+48.0% | $23.7M+71.5% |
| SG&A Expenses | $14.6M+71.8% | $10.5M+87.5% | $11.4M+125.3% | $7.3M+0.5% | $8.5M-1.7% | $5.6M-28.2% | $5.1M-29.5% | $7.2M+16.8% |
| Operating Income | -$50.6M-23.1% | -$47.9M-80.1% | -$45.1M-88.9% | -$34.3M-13.0% | -$41.1M-21.4% | -$26.6M+6.9% | -$23.9M-100.2% | -$30.3M-66.0% |
| Income Tax | $200K+100.0% | $200K | $391K+5485.7% | $0 | $100K | $0-100.0% | $7K+216.7% | $0 |
| Net Income | -$50.4M-20.3% | -$47.6M-75.6% | -$44.8M-94.6% | -$33.2M-8.9% | -$41.9M-26.5% | -$27.1M+0.9% | -$23.0M-106.0% | -$30.4M-81.9% |
| EPS (Basic) | -$0.12+61.3% | -$0.11+57.7% | -$0.23-4.5% | -$0.24+25.0% | -$0.31+8.8% | -$0.26+7.1% | -$0.22-100.0% | -$0.32-88.2% |
| EPS (Diluted) | -$0.12 | -$0.11 | -$0.23 | -$0.24+25.0% | -$0.31+8.8% | -$0.26+7.1% | -$0.22-100.0% | -$0.32-88.2% |
| Diluted Shares (Avg) | 434M | 428M | N/A | 137M+42.2% | 134M+39.8% | 103M+6.7% | N/A | 96M+0.1% |
Not reported in any period shown, so not listed: Cost of Revenue, Gross Profit, EBITDA, Interest Expense.
DBVT Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $223.2M+55.6% | $266.4M+426.9% | $233.7M+255.9% | $110.5M+18.7% | $143.4M+25.6% | $50.6M-65.3% | $65.7M-64.1% | $93.1M-51.0% |
| Current Assets | $201.9M+66.5% | $246.7M+746.4% | $212.9M+379.6% | $88.9M+29.3% | $121.2M+34.8% | $29.1M-75.6% | $44.4M-72.1% | $68.8M-59.4% |
| Cash & Equivalents | $174.9M+69.5% | $229.2M+1668.2% | $194.2M+498.3% | $69.8M+50.4% | $103.2M+55.9% | $13.0M-87.2% | $32.5M-77.0% | $46.4M-68.9% |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $62.8M+9.8% | $58.4M+22.5% | $64.9M+69.6% | $57.6M+47.7% | $57.2M+63.0% | $47.7M+39.3% | $38.3M-10.6% | $39.0M-14.8% |
| Current Liabilities | $54.3M+9.9% | $51.8M+28.3% | $58.0M+86.3% | $49.5M+60.1% | $49.4M+80.5% | $40.4M+52.5% | $31.1M-16.6% | $30.9M-1.7% |
| Non-Current Liabilities | $8.5M+9.3% | $6.7M-8.3% | $6.9M-3.3% | $8.2M+0.6% | $7.8M+0.9% | $7.3M-5.8% | $7.1M+30.7% | $8.1M-43.5% |
| Total Equity | $160.4M+86.1% | $207.9M+7069.0% | $168.8M+516.1% | $52.9M-2.2% | $86.2M+9.0% | $2.9M-97.4% | $27.4M-80.5% | $54.0M-62.5% |
| Retained Earnings | -$270.3M+14.2% | -$440.7M-40.6% | -$393.1M-37.3% | -$348.3M-32.3% | -$315.1M-35.3% | -$313.5M-17.7% | -$286.4M-19.9% | -$263.3M-15.7% |
Not reported in any period shown, so not listed: Inventory, Accounts Receivable, Goodwill, Long-Term Debt.
DBVT Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -$52.6M-55.2% | -$49.1M-149.2% | -$35.2M-187.1% | -$32.4M-44.3% | -$33.9M+3.3% | -$19.7M+43.2% | -$12.3M+10.5% | -$22.5M-14.7% |
| Stock-Based Compensation | $3.7M+208.3% | $2.3M+35.3% | N/A | $516K-67.5% | $1.2M-21.3% | $1.7M-13.2% | N/A | $1.6M+17.5% |
| Capital Expenditures | $400K | $400K | $373K+198.4% | $159K-59.8% | $0-100.0% | $0-100.0% | -$125K-64.5% | $396K+692.0% |
| Free Cash Flow | -$53.0M-56.3% | -$49.5M-151.3% | -$35.5M-187.2% | -$32.6M-42.5% | -$33.9M+5.3% | -$19.7M+45.3% | -$12.4M+11.8% | -$22.9M-16.5% |
| Investing Cash Flow | -$600K | -$300K+25.0% | -$715K-190.2% | -$254K-133.0% | $0-100.0% | -$400K+81.2% | $793K+524.1% | -$109K+66.1% |
| Financing Cash Flow | $100K-99.9% | $88.9M | $159.1M+23464.4% | $122K+1642.9% | $117.0M+354645.5% | $0+100.0% | $675K+457.1% | $7K+100.8% |
Not reported in any period shown, so not listed: Depreciation & Amortization, Dividends Paid, Share Buybacks.
DBVT Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Operating Margin | -7228.6% | -5322.2% | -8021.2% | -1235.7% | -2740.0% | -3325.0% | -4669.5% | -2829.1% |
| Net Margin | -7200.0% | -5288.9% | -7968.5% | -1195.5% | -2793.3% | -3387.5% | -4503.9% | -2839.7% |
| Return on Equity | -31.4%+17.2pp | -22.9%+911.6pp | -26.5%+57.5pp | -62.7%-6.4pp | -48.6%-6.7pp | -934.5%-910.0pp | -84.0%-76.0pp | -56.3%-44.7pp |
| Return on Assets | -22.6%+6.6pp | -17.9%+35.7pp | -19.2%+15.9pp | -30.0%+2.7pp | -29.2%-0.2pp | -53.6%-34.9pp | -35.0%-28.9pp | -32.7%-23.9pp |
| Current Ratio | 3.72+1.3x | 4.76+4.0x | 3.67+2.2x | 1.80-0.4x | 2.45-0.8x | 0.72-3.8x | 1.43-2.8x | 2.22-3.2x |
| Debt-to-Equity | 0.39-0.3x | 0.28-16.2x | 0.38-1.0x | 1.09+0.4x | 0.66+0.2x | 16.44+16.1x | 1.40+1.1x | 0.72+0.4x |
| Asset Turnover | 0.000.0x | 0.000.0x | 0.000.0x | 0.030.0x | 0.010.0x | 0.020.0x | 0.010.0x | 0.010.0x |
| FCF Margin | -7571.4% | -5500.0% | -6324.9% | -1174.0% | -2260.0% | -2462.5% | -2422.1% | -2131.8% |
Not reported in any period shown, so not listed: Gross Margin.
Reported as filed but not readable as a share of revenue in the periods where the ratio runs further from zero than a revenue base allows; no change figure is given where either compared period is one of those: Operating Margin, Net Margin, FCF Margin.
Similar Companies
Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.
| Company | Fiscal year | Revenue | Net income | Net margin | Market cap | Health score |
|---|---|---|---|---|---|---|
| DBV Technologies S.A. DBVT | FY2025 | $5.6M | -$146.9M | N/A | $615.9M | 45/100 |
| Omeros Corporation OMER | FY2025 | N/A | N/A | N/A | $1.4B | — |
| Candel Therapeutics, Inc. CADL | FY2025 | N/A | -$38.2M | N/A | $760.6M | — |
| Capricor Therapeutics Inc CAPR | FY2025 | $0 | -$105.0M | N/A | $455.2M | — |
| Neurogene, Inc. NGNE | FY2025 | $0 | -$90.4M | N/A | $528.3M | — |
| Annexon, Inc. ANNX | FY2025 | N/A | -$206.7M | N/A | $762.1M | — |
Where DBV Technologies S.A. Ranks
Frequently Asked Questions
What is DBV Technologies S.A.'s annual revenue?
DBV Technologies S.A. (DBVT) reported $5.6M in total revenue for fiscal year 2025. This represents a 35.8% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is DBV Technologies S.A.'s revenue growing?
DBV Technologies S.A. (DBVT) revenue grew by 35.8% year-over-year, from $4.2M to $5.6M in fiscal year 2025.
Is DBV Technologies S.A. profitable?
No, DBV Technologies S.A. (DBVT) reported a net income of -$146.9M in fiscal year 2025.
What is DBV Technologies S.A.'s EBITDA?
DBV Technologies S.A. (DBVT) had EBITDA of -$144.1M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
What is DBV Technologies S.A.'s return on equity (ROE)?
DBV Technologies S.A. (DBVT) has a return on equity of -87.1% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is DBV Technologies S.A.'s free cash flow?
DBV Technologies S.A. (DBVT) recorded an outflow of $121.7M in free cash flow during fiscal year 2025. This represents a -14.0% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is DBV Technologies S.A.'s operating cash flow?
DBV Technologies S.A. (DBVT) recorded an outflow of $121.2M in operating cash flow during fiscal year 2025, representing cash used by core business activities.
What are DBV Technologies S.A.'s total assets?
DBV Technologies S.A. (DBVT) had $233.7M in total assets as of fiscal year 2025, including both current and long-term assets.
What are DBV Technologies S.A.'s capital expenditures?
DBV Technologies S.A. (DBVT) invested $532K in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
How much does DBV Technologies S.A. spend on research and development?
DBV Technologies S.A. (DBVT) invested $116.7M in research and development during fiscal year 2025.
What is DBV Technologies S.A.'s current ratio?
DBV Technologies S.A. (DBVT) had a current ratio of 3.67 as of fiscal year 2025, which is generally considered healthy.
What is DBV Technologies S.A.'s debt-to-equity ratio?
DBV Technologies S.A. (DBVT) had a debt-to-equity ratio of 0.38 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is DBV Technologies S.A.'s return on assets (ROA)?
DBV Technologies S.A. (DBVT) had a return on assets of -62.9% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is DBV Technologies S.A.'s P/E ratio?
DBV Technologies S.A. (DBVT) has no price-to-earnings ratio at the moment: net loss, so no earnings multiple (trailing 12 months to June 30, 2026). The market capitalization is $615.9M as of Oct 10, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is DBV Technologies S.A.'s price-to-sales ratio?
DBV Technologies S.A. (DBVT) trades at 125x sales, its market capitalization divided by revenue of $4.9M revenue, trailing 12 months to June 30, 2026. The market capitalization is $615.9M as of Oct 10, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
How does DBV Technologies S.A.'s liquidity compare with its operating cash outflow?
At the end of fiscal year 2025, DBV Technologies S.A. (DBVT) held $194.2M in cash, cash equivalents and investments, and reported an operating cash outflow of $121.2M over that year. Dividing the one by the other, the reported balance equals about 19 months of the outflow reported that year. This is arithmetic over figures already filed, not a projection: it assumes nothing about future spending, financing or operations.
What is DBV Technologies S.A.'s Altman Z-Score?
DBV Technologies S.A. (DBVT) has an Altman Z-Score of 2.08, placing it in the Grey Zone (moderate risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
What is DBV Technologies S.A.'s Piotroski F-Score?
DBV Technologies S.A. (DBVT) has a Piotroski F-Score of 3 out of 7 computable signals; 2 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are DBV Technologies S.A.'s earnings high quality?
DBV Technologies S.A. (DBVT) reported a net loss of $146.9M while operations used $121.2M of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
How financially healthy is DBV Technologies S.A.?
DBV Technologies S.A. (DBVT) scores 45 out of 100 on our Financial Health Score, indicating moderate standing within its emerging companies peer group. The score is a 0-100 composite of six dimensions (Cash Runway, Dilution, R&D Intensity, Revenue Progress, Burn Trend, Balance Sheet), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.